Notice on Convening the 2025 Annual General Meeting
Filed with SSE · · 7 pages · Chinese
Summary by 6ix AI
The notice outlines the agenda items to be discussed and voted on during the meeting, including the annual report and profit distribution proposal. Shareholders are required to register for the meeting in advance, with specific instructions provided for both individual and institutional participants.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Zhejiang Jianfeng Group Co. Ltd. on 6ix
Earlier from Zhejiang Jianfeng
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Subsidiary Obtaining a Notice of Disapproval for the Drug Marketing Authorization Application
- Earnings Preannouncement for 2025
- Announcement on Withdrawal of Clinical Trail Application for Drug Registration by Subsidiary
- Announcement on Subsidiary's Passing GMP Compliance Inspection for Drugs
Later from Zhejiang Jianfeng
- Announcement on Implementation Result of Shares Repurchase and Share Changes
- Announcement on Withdrawal of Drug Registration Application by the Subsidiary
- Report for Q1 2026
- Announcement on Subsidiary Obtaining Approval for Marketing of Chemical APIs
- Announcement on Resolutions of the 2025 Annual General Meeting
Follow Zhejiang Jianfeng into a list and get an email when it puts out news.
Follow Zhejiang Jianfeng